527 related articles for article (PubMed ID: 23111637)
1. Roles of Wnt signals in bone resorption during physiological and pathological states.
Maeda K; Takahashi N; Kobayashi Y
J Mol Med (Berl); 2013 Jan; 91(1):15-23. PubMed ID: 23111637
[TBL] [Abstract][Full Text] [Related]
2. Regulatory mechanism of osteoclastogenesis by RANKL and Wnt signals.
Takahashi N; Maeda K; Ishihara A; Uehara S; Kobayashi Y
Front Biosci (Landmark Ed); 2011 Jan; 16(1):21-30. PubMed ID: 21196156
[TBL] [Abstract][Full Text] [Related]
3. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.
Maeda K; Kobayashi Y; Udagawa N; Uehara S; Ishihara A; Mizoguchi T; Kikuchi Y; Takada I; Kato S; Kani S; Nishita M; Marumo K; Martin TJ; Minami Y; Takahashi N
Nat Med; 2012 Feb; 18(3):405-12. PubMed ID: 22344299
[TBL] [Abstract][Full Text] [Related]
4. [Regulation of osteoclast differentiation by Wnt signals].
Kobayashi Y
Clin Calcium; 2013 Jun; 23(6):831-8. PubMed ID: 23719495
[TBL] [Abstract][Full Text] [Related]
5. Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow.
Mousa A; Cui C; Song A; Myneni VD; Sun H; Li JJ; Murshed M; Melino G; Kaartinen MT
Cell Death Differ; 2017 May; 24(5):844-854. PubMed ID: 28387755
[TBL] [Abstract][Full Text] [Related]
6. Regulation of bone metabolism by Wnt signals.
Kobayashi Y; Uehara S; Udagawa N; Takahashi N
J Biochem; 2016 Apr; 159(4):387-92. PubMed ID: 26711238
[TBL] [Abstract][Full Text] [Related]
7. Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption.
Kitaura H; Marahleh A; Ohori F; Noguchi T; Shen WR; Qi J; Nara Y; Pramusita A; Kinjo R; Mizoguchi I
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708317
[TBL] [Abstract][Full Text] [Related]
8. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
9. Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption.
Xiong L; Jung JU; Wu H; Xia WF; Pan JX; Shen C; Mei L; Xiong WC
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3487-92. PubMed ID: 25733894
[TBL] [Abstract][Full Text] [Related]
10. Stimuli and Relevant Signaling Cascades for NFATc1 in Bone Cell Homeostasis: Friend or Foe?
Zhang Z; Wen H; Yang X; Zhang K; He B; Zhang X; Kong L
Curr Stem Cell Res Ther; 2019; 14(3):239-243. PubMed ID: 30516111
[TBL] [Abstract][Full Text] [Related]
11. Activation of mTORC1 in B Lymphocytes Promotes Osteoclast Formation via Regulation of β-Catenin and RANKL/OPG.
Xu S; Zhang Y; Liu B; Li K; Huang B; Yan B; Zhang Z; Liang K; Jia C; Lin J; Zeng C; Cai D; Jin D; Jiang Y; Bai X
J Bone Miner Res; 2016 Jul; 31(7):1320-33. PubMed ID: 26825871
[TBL] [Abstract][Full Text] [Related]
12. Low levels of cadmium exposure affect bone by inhibiting Lgr4 expression in osteoblasts and osteoclasts.
Wang M; Liu J; Zhu G; Chen X
J Trace Elem Med Biol; 2022 Sep; 73():127025. PubMed ID: 35772369
[TBL] [Abstract][Full Text] [Related]
13. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
14. Osteoclast differentiation by RANKL and OPG signaling pathways.
Udagawa N; Koide M; Nakamura M; Nakamichi Y; Yamashita T; Uehara S; Kobayashi Y; Furuya Y; Yasuda H; Fukuda C; Tsuda E
J Bone Miner Metab; 2021 Jan; 39(1):19-26. PubMed ID: 33079279
[TBL] [Abstract][Full Text] [Related]
15. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
[TBL] [Abstract][Full Text] [Related]
16. Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.
Baum R; Gravallese EM
Clin Rev Allergy Immunol; 2016 Aug; 51(1):1-15. PubMed ID: 26411424
[TBL] [Abstract][Full Text] [Related]
17. Sfrp4 repression of the Ror2/Jnk cascade in osteoclasts protects cortical bone from excessive endosteal resorption.
Chen K; Ng PY; Chen R; Hu D; Berry S; Baron R; Gori F
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14138-14143. PubMed ID: 31239337
[TBL] [Abstract][Full Text] [Related]
18. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
[TBL] [Abstract][Full Text] [Related]
19. The mammalian lectin galectin-8 induces RANKL expression, osteoclastogenesis, and bone mass reduction in mice.
Vinik Y; Shatz-Azoulay H; Vivanti A; Hever N; Levy Y; Karmona R; Brumfeld V; Baraghithy S; Attar-Lamdar M; Boura-Halfon S; Bab I; Zick Y
Elife; 2015 May; 4():e05914. PubMed ID: 25955862
[TBL] [Abstract][Full Text] [Related]
20. Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion.
Okayasu M; Nakayachi M; Hayashida C; Ito J; Kaneda T; Masuhara M; Suda N; Sato T; Hakeda Y
J Biol Chem; 2012 Jun; 287(23):19229-41. PubMed ID: 22500026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
